Document ID: chunk:federal_register_of_legislation:F2019L01095:reg:9:p3
Version: federal_register_of_legislation:F2019L01095
Segment Type: reg
Provision Reference: reg 9 (pt 3/3)
Character Range: 9429–10688

of the affected side, at the time of the clinical worsening of conductive hearing loss;
Note: chronic otitis media is defined in the Schedule 1 - Dictionary.
(22)      having:
(a)          a benign or malignant neoplasm; or
(b)          other mass lesion;
involving the middle ear of the affected side, at the time of the clinical worsening of conductive hearing loss;
            Note: Examples of neoplasms or mass lesions involving the middle ear include, but are not limited to:
              (a)                       cholesteatoma;
              (b)       granuloma; and
              (c)         neuroendocrine adenoma.

         (23)      having a disease from the specified list of autoimmune diseases, at the time of the clinical worsening of conductive hearing loss;
Note: specified list of autoimmune diseases is defined in the Schedule 1 – Dictionary.

         (24)      undergoing a course of therapeutic radiation for cancer, where the conductive hearing apparatus of the affected side was in the field of radiation, before the clinical worsening of conductive hearing loss;
Note: conductive hearing apparatus is defined in the Schedule 1 – Dictionary.
(25)      inability to obtain appropriate clinical management for conductive hearing loss.